Zymeworks (ZYME) Announces Expanded Bispecific Antibody Collaboration with Celgene Corp. (CELG)
Tweet Send to a Friend
Zymeworks Inc. (NYSE: ZYME) today announced that Celgene Corporation (NASDAQ: CELG) has exercised its right to expand its collaboration agreement ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE